2023
DOI: 10.1016/s0016-5085(23)02000-0
|View full text |Cite
|
Sign up to set email alerts
|

Sa1786 THE USE OF VEDOLIZUMAB MAY INCREASE THE RISK OF CLOSTRIDIUM DIFFICILE INFECTION IN IBD PATIENTS ON BIOLOGIC THERAPY

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles